Cargando…

Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies

Detalles Bibliográficos
Autores principales:	Mohan, Meera, Nagavally, Sneha, Shah N, Nirav N, Michaelis, Laura, Chhabra, Saurabh, Souza, Anita D, Abedin, Sameem, Runaas, Lyndsey, Guru Murthy, Guru Subramanian, Longo, Walter, Hamadani, Mehdi, Dhakal, Binod, Hari, Parameswaran, Fenske, Timothy S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767926/ https://www.ncbi.nlm.nih.gov/pubmed/35148976 http://dx.doi.org/10.1016/j.clml.2022.01.010

Ejemplares similares

Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy
por: Dhakal, Binod, et al.
Publicado: (2021)

Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients
por: Abid, Muhammad Bilal, et al.
Publicado: (2022)

Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2022)

Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib
por: Abidi, Maheen Z., et al.
Publicado: (2016)

Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome
por: Corrao, Kristen, et al.
Publicado: (2022)

Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma
por: Dhakal, Binod, et al.
Publicado: (2019)

Letter to the Editor Regarding “Diagnostic Considerations for COVID-19 in Recipients of Allogeneic Hematopoietic Cell Transplantation”
por: Chhabra, Saurabh, et al.
Publicado: (2020)

Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis
por: D'Souza, Anita, et al.
Publicado: (2017)

Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination
por: Chhabra, Saurabh, et al.
Publicado: (2022)

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
por: Abedin, Sameem, et al.
Publicado: (2020)

Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol
por: Johnson, Alexander K., et al.
Publicado: (2022)

How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice
por: Guru Murthy, Guru Subramanian
Publicado: (2022)

Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial
por: D'Souza, Anita, et al.
Publicado: (2020)

Bronchoalveolar lavage-based COVID-19 testing in patients with cancer
por: Abid, Muhammad Bilal, et al.
Publicado: (2021)

Recent advances in understanding multiple myeloma
por: Dhakal, Binod, et al.
Publicado: (2016)

Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation
por: Knight, Jennifer M., et al.
Publicado: (2018)

P1082: RESULTS FROM A PHASE 1/2 STUDY OF TANDEM, BISPECIFIC ANTI-CD20/ANTI-CD19 (LV20.19) CAR T-CELLS FOR MANTLE CELL LYMPHOMA
por: Shah, Nirav N, et al.
Publicado: (2023)

Prevalence and Significance of Sarcopenia in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation
por: Williams, Alexis, et al.
Publicado: (2020)

Blood and Marrow Transplantation (BMT) within Four Weeks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study
por: Mohan, Meera, et al.
Publicado: (2022)

Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma
por: Pisano, Michael, et al.
Publicado: (2021)

Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
por: Hammons, Lindsay R., et al.
Publicado: (2022)

Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapy
por: Furqan, Fateeha, et al.
Publicado: (2022)

Pretransplant Splenic Irradiation in Patients With Myeloproliferative Neoplasms
por: Ponce, Sara Beltrán, et al.
Publicado: (2022)

A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics
por: Awada, Hassan, et al.
Publicado: (2021)

Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study
por: Dong, Jing, et al.
Publicado: (2022)

Milker’s nodule: An under‐reported and under‐diagnosed occupational infection
por: Poudel, Guru Prasad, et al.
Publicado: (2020)

Baseline CD4 count and the time interval between the initial HIV infection and diagnosis among PLHIV in Bhutan
por: khandu, Lekey, et al.
Publicado: (2021)

Shorter mothers have shorter pregnancies
por: Derraik, José, et al.
Publicado: (2015)

P636: A FIRST-IN-HUMAN PHASE 1 STUDY OF ORAL LOXO-338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES
por: Kwiatek, Michal, et al.
Publicado: (2023)

Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
por: Shah, Nirav N., et al.
Publicado: (2019)

The effect of Emblica officinalis diet on lifespan, sexual behavior, and fitness characters in Drosophila melanogaster
por: Pathak, Pankaj, et al.
Publicado: (2011)

S203: QUADRUPLET INDUCTION THERAPY, ASCT AND MRD-MODULATED CONSOLIDATION AND TREATMENT CESSATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL ANALYSIS OF THE MASTER TRIAL
por: Costa, Luciano, et al.
Publicado: (2023)

Shorter Sleep Predicts Longer Subsequent Day Sedentary Duration in Healthy Midlife Adults, but Not in Those with Sleep Apnea
por: Thosar, Saurabh S, et al.
Publicado: (2021)

BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects
por: Abedin, Sameem M, et al.
Publicado: (2016)

Gut microbiome and CAR-T therapy
por: Abid, Muhammad Bilal, et al.
Publicado: (2019)

Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse
por: Dhakal, Binod, et al.
Publicado: (2022)

CAR T-cell therapy for secondary CNS DLBCL
por: Ahmed, Gulrayz, et al.
Publicado: (2021)

Knowledge of health workers on snakes and snakebite management and treatment seeking behavior of snakebite victims in Bhutan
por: Sapkota, Sunil, et al.
Publicado: (2020)

Adherence to Antibiotic Stewardship Program Associated with Shorter Course of Treatment and Fewer Adverse Events
por: Mulligan, Patrick, et al.
Publicado: (2021)

Mechanochemical Synthesis of Nanocrystalline Hydroxyapatite from Ca(H(2)PO(4))(2).H(2)O, CaO, Ca(OH)(2), and P(2)O(5) Mixtures
por: Dinda, Sneha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rmn441cgor9kte31mqob8hpjaj